Market Overview:
The global carbohydrate antigen market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of cancer, technological advancements in the field of diagnostics, and rising demand for early diagnosis and treatment of cancer. The global carbohydrate antigen market by type is segmented into CA199, CA125, CA242, and CA724. The malignant tumors of the digestive tract segment accounted for the largest share in 2017 and is projected to grow at a CAGR of 7.8% during the forecast period. This can be attributed to factors such as increasing incidence rates of gastrointestinal cancers across the globe and growing awareness about these cancers among patients and healthcare professionals alike. The global carbohydrate antigen market by application is segmented into malignant tumors of the digestive tract, application in diagnosing pancreatic cancer, other malignant tumors (including ovarian cancer), non-neoplastic diseases (such as autoimmune diseases), and others (including research applications). The malignant tumors of digestive tract segment accounted for majority share in 2017 owing to high incidence rates associated with various types gastrointestinal cancers such as colorectal cancer, pancreatic cancer etc.
Product Definition:
A carbohydrate antigen is a type of molecule that is found on the surface of cells and helps to identify them. These molecules are important for immune system function, and can be used to diagnose certain diseases.
CA199:
CA199 is a new diagnostic term for Carbohydrate Intolerance Disease (CID) or carbohydrate intolerance. CA199 was previously known as CDG (Carbohydrate-Deficiency Gastrointestinal) and was included in the list of recognized entities by The International Society for the Study of Fatty Acids and Lipids. However, it has recently been reclassified as a separate disease entity under the name “CA 199” by The American College of Gastroenterology in July 2013.
CA125:
CA 125 is a protein that is found in the blood cells. It's main function is to identify foreign objects such as bacteria and viruses. When there are many cancer-causing viruses or bacteria in the body, this test can detect it because it helps find these foreign objects. This test also finds out if there are any cancerous (tumor) cells in the body.
Application Insights:
The application segment includes malignant tumors of the digestive tract, other malignant tumors, and non-neoplastic disease. The digestive tumor segment dominated the market in 2017 due to increasing incidence of cancer in developed countries such as U.S., Canada, Germany and France. In addition, growing demand for diagnostic tests is expected to drive growth during the forecast period.
CA125 antigen testing is used as a biomarker for pancreatic cancer diagnosis based on its high specificity and sensitivity (0.9). It has been estimated that approximately 90% of pancreatic cancers express CA125 antigen which makes it an ideal biomarker for this purpose (Owen et al., 2014). Moreover, several research studies have supported its usage in screening population at high risk of developing pancreatic cancer owing to family history or early onset diabetes (Gronwald et al., 2016; Li et al., 2018).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased research activities, and high incidence rate of cancer in this region. Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing prevalence of cancer and other chronic diseases coupled with rising awareness about CA testing among people. Moreover, government initiatives for improving healthcare infrastructure are also expected to drive regional market growth over the forecast period.
In addition, growing medical tourism industry due to affordable treatment cost coupled with favorable government policies regarding immigration is further anticipated boost demand for Carbohydrate Antigen Testing In The Region (CTIR).
On average 4500 new cases were reported per year in U.
Growth Factors:
- Increasing prevalence of chronic diseases such as diabetes and cancer is expected to drive the demand for carbohydrate antigen tests over the forecast period.
- Growing awareness about early diagnosis and treatment of chronic diseases will propel the demand for carbohydrate antigen tests.
- Technological advancements in diagnostic methods are anticipated to boost the growth of global carbohydrate antigen market during the forecast period.
- Rising number of mergers and acquisitions by key players is expected to provide impetus to market growth during the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Carbohydrate Antigen Market Research Report
By Type
CA199, CA125, CA242, CA724
By Application
Malignant Tumors of The Digestive Tract, Application in The Diagnosis of Pancreatic Cancer, Other Malignant Tumors, Non-neoplastic Disease
By Companies
Siemens, H.U. Group Holdings, Tosoh, Carlyle Group, Abbott, Roche, Danaher, Compagnie Merieux Alliance SAS, American Standard Companies, KAINOS LABORATORIES, INC, Sofina
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Carbohydrate Antigen Market Report Segments:
The global Carbohydrate Antigen market is segmented on the basis of:
Types
CA199, CA125, CA242, CA724
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Malignant Tumors of The Digestive Tract, Application in The Diagnosis of Pancreatic Cancer, Other Malignant Tumors, Non-neoplastic Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens
- H.U. Group Holdings
- Tosoh
- Carlyle Group
- Abbott
- Roche
- Danaher
- Compagnie Merieux Alliance SAS
- American Standard Companies
- KAINOS LABORATORIES, INC
- Sofina
Highlights of The Carbohydrate Antigen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CA199
- CA125
- CA242
- CA724
- By Application:
- Malignant Tumors of The Digestive Tract
- Application in The Diagnosis of Pancreatic Cancer
- Other Malignant Tumors
- Non-neoplastic Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Carbohydrate Antigen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Carbohydrate antigen is a protein that helps the body to identify and digest carbohydrates.
Some of the major companies in the carbohydrate antigen market are Siemens, H.U. Group Holdings, Tosoh, Carlyle Group, Abbott, Roche, Danaher, Compagnie Merieux Alliance SAS, American Standard Companies, KAINOS LABORATORIES, INC, Sofina.
The carbohydrate antigen market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Carbohydrate Antigen Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Carbohydrate Antigen Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Carbohydrate Antigen Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Carbohydrate Antigen Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Carbohydrate Antigen Market Size & Forecast, 2018-2028 4.5.1 Carbohydrate Antigen Market Size and Y-o-Y Growth 4.5.2 Carbohydrate Antigen Market Absolute $ Opportunity
Chapter 5 Global Carbohydrate Antigen Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Carbohydrate Antigen Market Size Forecast by Type
5.2.1 CA199
5.2.2 CA125
5.2.3 CA242
5.2.4 CA724
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Carbohydrate Antigen Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Carbohydrate Antigen Market Size Forecast by Applications
6.2.1 Malignant Tumors of The Digestive Tract
6.2.2 Application in The Diagnosis of Pancreatic Cancer
6.2.3 Other Malignant Tumors
6.2.4 Non-neoplastic Disease
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Carbohydrate Antigen Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Carbohydrate Antigen Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Carbohydrate Antigen Analysis and Forecast
9.1 Introduction
9.2 North America Carbohydrate Antigen Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Carbohydrate Antigen Market Size Forecast by Type
9.6.1 CA199
9.6.2 CA125
9.6.3 CA242
9.6.4 CA724
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Carbohydrate Antigen Market Size Forecast by Applications
9.10.1 Malignant Tumors of The Digestive Tract
9.10.2 Application in The Diagnosis of Pancreatic Cancer
9.10.3 Other Malignant Tumors
9.10.4 Non-neoplastic Disease
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Carbohydrate Antigen Analysis and Forecast
10.1 Introduction
10.2 Europe Carbohydrate Antigen Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Carbohydrate Antigen Market Size Forecast by Type
10.6.1 CA199
10.6.2 CA125
10.6.3 CA242
10.6.4 CA724
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Carbohydrate Antigen Market Size Forecast by Applications
10.10.1 Malignant Tumors of The Digestive Tract
10.10.2 Application in The Diagnosis of Pancreatic Cancer
10.10.3 Other Malignant Tumors
10.10.4 Non-neoplastic Disease
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Carbohydrate Antigen Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Carbohydrate Antigen Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Carbohydrate Antigen Market Size Forecast by Type
11.6.1 CA199
11.6.2 CA125
11.6.3 CA242
11.6.4 CA724
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Carbohydrate Antigen Market Size Forecast by Applications
11.10.1 Malignant Tumors of The Digestive Tract
11.10.2 Application in The Diagnosis of Pancreatic Cancer
11.10.3 Other Malignant Tumors
11.10.4 Non-neoplastic Disease
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Carbohydrate Antigen Analysis and Forecast
12.1 Introduction
12.2 Latin America Carbohydrate Antigen Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Carbohydrate Antigen Market Size Forecast by Type
12.6.1 CA199
12.6.2 CA125
12.6.3 CA242
12.6.4 CA724
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Carbohydrate Antigen Market Size Forecast by Applications
12.10.1 Malignant Tumors of The Digestive Tract
12.10.2 Application in The Diagnosis of Pancreatic Cancer
12.10.3 Other Malignant Tumors
12.10.4 Non-neoplastic Disease
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Carbohydrate Antigen Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Carbohydrate Antigen Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Carbohydrate Antigen Market Size Forecast by Type
13.6.1 CA199
13.6.2 CA125
13.6.3 CA242
13.6.4 CA724
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Carbohydrate Antigen Market Size Forecast by Applications
13.10.1 Malignant Tumors of The Digestive Tract
13.10.2 Application in The Diagnosis of Pancreatic Cancer
13.10.3 Other Malignant Tumors
13.10.4 Non-neoplastic Disease
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Carbohydrate Antigen Market: Competitive Dashboard
14.2 Global Carbohydrate Antigen Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens
14.3.2 H.U. Group Holdings
14.3.3 Tosoh
14.3.4 Carlyle Group
14.3.5 Abbott
14.3.6 Roche
14.3.7 Danaher
14.3.8 Compagnie Merieux Alliance SAS
14.3.9 American Standard Companies
14.3.10 KAINOS LABORATORIES, INC
14.3.11 Sofina